Cargando…

Nurse-assisted and multidisciplinary outpatient follow-up among patients with decompensated liver cirrhosis: A systematic review

BACKGROUND AND OBJECTIVE: Liver cirrhosis represents a considerable health burden and causes 1.2 million deaths annually. Patients with decompensated liver cirrhosis have a poor prognosis and severely reduced health-related quality of life. Nurse-led outpatient care has proven safe and feasible for...

Descripción completa

Detalles Bibliográficos
Autores principales:	O’Connell, Malene Barfod, Bendtsen, Flemming, Nørholm, Vibeke, Brødsgaard, Anne, Kimer, Nina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9910708/ https://www.ncbi.nlm.nih.gov/pubmed/36758017 http://dx.doi.org/10.1371/journal.pone.0278545

Ejemplares similares

Markers of inflammation predict survival in newly diagnosed cirrhosis: a prospective registry study
por: Mynster Kronborg, Thit, et al.
Publicado: (2023)

Blunted cardiovascular effects of beta-blockers in patients with cirrhosis: Relation to severity?
por: Nabilou, Puria, et al.
Publicado: (2022)

No effect of rifaximin on soluble CD163, mannose receptor or type III and IV neoepitope collagen markers in decompensated cirrhosis: Results from a randomized, placebo controlled trial
por: Kimer, Nina, et al.
Publicado: (2018)

Atorvastatin for prevention of disease progression and hospitalisation in liver cirrhosis: protocol for a randomised, double-blind, placebo-controlled trial
por: Kimer, Nina, et al.
Publicado: (2020)

Differential inflammasome activation predisposes to acute-on-chronic liver failure in human and experimental cirrhosis with and without previous decompensation
por: Monteiro, Sofia, et al.
Publicado: (2021)

Medication‐Related Problems in Outpatients With Decompensated Cirrhosis: Opportunities for Harm Prevention
por: Hayward, Kelly L., et al.
Publicado: (2019)

Collagen type IV remodelling gender‐specifically predicts mortality in decompensated cirrhosis
por: Lehmann, Jennifer, et al.
Publicado: (2019)

Balancing responsibilities, rewards and challenges: A qualitative study illuminating the complexity of being a rapid response team nurse
por: Bunkenborg, Gitte, et al.
Publicado: (2022)

Randomized intervention and outpatient follow-up lowers 30-d readmissions for patients with hepatic encephalopathy, decompensated cirrhosis
por: Pusateri, Antoinette, et al.
Publicado: (2023)

British Society of Gastroenterology Best Practice Guidance: outpatient management of cirrhosis – part 2: decompensated cirrhosis
por: Mansour, Dina, et al.
Publicado: (2023)

Atorvastatin for patients with cirrhosis. A randomized, placebo-controlled trial
por: Kronborg, Thit M., et al.
Publicado: (2023)

Acute decompensation boosts hepatic collagen type III deposition and deteriorates experimental and human cirrhosis
por: Praktiknjo, Michael, et al.
Publicado: (2018)

Improving Survival in Decompensated Cirrhosis
por: Mukerji, Amar Nath, et al.
Publicado: (2012)

Management options in decompensated cirrhosis
por: Shah, Neeral L, et al.
Publicado: (2015)

COVID-19 in decompensated cirrhosis
por: Rela, Mohamed, et al.
Publicado: (2020)

Decompensation of Cirrhosis: An Unusual Cause
por: Rudra, Omkar S, et al.
Publicado: (2022)

Identifying cirrhosis, decompensated cirrhosis and hepatocellular carcinoma in health administrative data: A validation study
por: Lapointe-Shaw, Lauren, et al.
Publicado: (2018)

Pregnancy Is Not Associated with an Increased Risk of Decompensation, Transplant, or Death in Compensated Cirrhosis
por: Mullin, Monica, et al.
Publicado: (2022)

Improving Survival in Patients with Decompensated Cirrhosis
por: Amarapurkar, Deepak, et al.
Publicado: (2011)

Suboptimal diagnostic accuracy of ultrasound and CT for compensated cirrhosis: Evidence from prospective cohort studies
por: Hetland, Liv E., et al.
Publicado: (2023)

Hepatitis C Treatment Outcomes in Persons With HIV and Decompensated Cirrhosis Using a Collaborative Multidisciplinary HIV-Centered Approach
por: Cachay, Edward R., et al.
Publicado: (2021)

Outpatient albumin infusions reduce hospitalizations and improve outcomes in decompensated cirrhosis: A real‐world cohort study
por: Hannah, Nicholas, et al.
Publicado: (2023)

Novel Anti-inflammatory Treatments in Cirrhosis. A Literature-Based Study
por: Kronborg, Thit Mynster, et al.
Publicado: (2021)

Treatment of Hepatitis B in Decompensated Liver Cirrhosis
por: Guan, Richard, et al.
Publicado: (2011)

Prescribing Medications in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Deepak N.
Publicado: (2011)

Management of Coagulopathy in Patients with Decompensated Liver Cirrhosis
por: Amarapurkar, Pooja D., et al.
Publicado: (2011)

Glycated Hemoglobin Levels in Patients with Decompensated Cirrhosis
por: Nadelson, Jeffrey, et al.
Publicado: (2016)

Frequency of gallstones and mean BMI in decompensated cirrhosis
por: Rai, Ayesha Aslam, et al.
Publicado: (2018)

Clinical impact of microbiome in patients with decompensated cirrhosis
por: Oikonomou, Theodora, et al.
Publicado: (2018)

Albumin in decompensated cirrhosis: new concepts and perspectives
por: Bernardi, Mauro, et al.
Publicado: (2020)

Micronutrient Deficiencies in Patients with Decompensated Liver Cirrhosis
por: Llibre-Nieto, Gemma, et al.
Publicado: (2021)

Acute Myeloid Leukemia Masquerading as Decompensated Cirrhosis
por: Ahdi, Hardeep S, et al.
Publicado: (2022)

Biomarkers of hepatocellular synthesis in patients with decompensated cirrhosis
por: Gurbuz, Berivan, et al.
Publicado: (2023)

Antimicrobial prophylaxis in decompensated cirrhosis: friend or foe?
por: Crocombe, Dominic, et al.
Publicado: (2023)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
por: Balcar, Lorenz, et al.
Publicado: (2022)

The impact of rifaximin on inflammation and metabolism in alcoholic hepatitis: A randomized clinical trial
por: Kimer, Nina, et al.
Publicado: (2022)

Buschke-Lowenstein tumor in a patient with decompensated cirrhosis
por: Shailesh, F. N. U., et al.
Publicado: (2014)

Serum Leptin Is a Biomarker of Malnutrition in Decompensated Cirrhosis
por: Rachakonda, Vikrant, et al.
Publicado: (2016)

Cryptococcemia in an HIV-negative patient with decompensated liver cirrhosis
por: Kandula, Manasa, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_a2hg9gubgrgbl331bpga9c1b5j